Practical strategy for optimizing the timing of anti-tumor necrosis factor-α therapy in Crohn disease: A nationwide population-based study

There is little consensus on the optimal timing of anti-tumor necrosis factor (anti-TNF) therapy to decrease the rates of hospitalization and surgery in Crohn disease (CD). We aimed to assess the real-world outcomes of anti-TNF therapy and estimate the optimal timing of anti-TNF therapy in Korean pa...

Descripción completa

Detalles Bibliográficos
Autores principales: Kwak, Min Seob, Cha, Jae Myung, Ahn, Ji Hyun, Chae, Min Kyu, Jeong, Sara, Lee, Hun Hee
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Wolters Kluwer Health 2020
Materias:
4500
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7478703/
https://www.ncbi.nlm.nih.gov/pubmed/32150045
http://dx.doi.org/10.1097/MD.0000000000018925

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7478703/
https://www.ncbi.nlm.nih.gov/pubmed/32150045
http://dx.doi.org/10.1097/MD.0000000000018925

Ejemplares similares